| Multiple Sclerosis |
1 |
1 |
| Pregnancy |
0 |
0.99 |
| Multiple Sclerosis Treatment |
0 |
0.47 |
| Disease-Modifying Therapy |
0 |
0.98 |
| Child |
0 |
0.31 |
| Face |
0 |
0.31 |
| Fertility |
0 |
0.31 |
| Multiple Sclerosis Risk |
0 |
0.31 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.27 |
| Birth |
0 |
0.16 |
| Clinical Research |
0 |
0.16 |
| Corticosteroids |
0 |
0.16 |
| Glatiramer Acetate |
0 |
0.16 |
| Grant |
0 |
0.16 |
| Immunoglobulin A (IgA) |
0 |
0.16 |
| Intravenous |
0 |
0.16 |
| Lactation |
0 |
0.16 |
| Match |
0 |
0.16 |
| Prematurity |
0 |
0.16 |